low molecular weight heparin, nadroparin (Fraxiparine), inhibits thrombin-induced platelet shape change and does not enhance spontaneous platelet aggregation-Reference-Cited by-同舟云学术

low molecular weight heparin, nadroparin (Fraxiparine), inhibits thrombin-induced platelet shape change and does not enhance spontaneous platelet aggregation

Published:1996-02 Issue:2 Volume:41 Page:163-165
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

JAGKOOP I. A.,BARRADAS M. A.,MIKHAILIDIS D. P.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1996.tb00176.x/fullpdf

Reference12 articles.

1. Low molecular weight heparin;Hirsh;Blood,1992

2. Nadroparin calcium: a review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders;Barradell;Drugs,1992

3. Role of thrombin and thromboxane A, in reocclusion following coronary thrombolysis with tissue-type plasminogen activator;Fitzgerald;Proc Natl Acad Sci USA,1989

4. Measurement of platelet volume using a channelyzer: assessment of the effect of agonists and antagonists;Barradas;In vivo,1992

5. The activation-induced decrease in the platelet surface expression of the glycoprotein Ib-IX complex is reversible;Michelson;Blood,1994

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heparin and platelet activation;Thrombosis Research;2012-10

2. The Effect of Tirofiban on Fibrinogen/Agonist-Induced Platelet Shape Change and Aggregation;Clinical and Applied Thrombosis/Hemostasis;2008-06-19

3. Effects of Bemiparin, Dalteparin, and Unfractionated Heparin on Platelet Interaction With Human Subendothelium Under Flow Conditions;Journal of Pharmacological Sciences;2008

4. Platelets and white blood cell subpopulations among patients with myocardial infarction and unstable angina;Platelets;2007-01

5. Heparin Therapy Leads to Platelet Activation and Prolongation of Platelet Function Analyser-100 Closure Time;Journal of Cardiovascular Pharmacology and Therapeutics;2006-06